CR UK, CRT Pioneer Fund and the NCI link on RAS
admin 19th April 2017 Uncategorised 0Cancer Research UK and the Cancer Research Technology Pioneer Fund are committing £2.5 million in collaboration with the US’ National Cancer Institute to tackle RAS, one of the most common driving mutations in aggressive, hard to treat cancers.
More: CR UK, CRT Pioneer Fund and the NCI link on RAS
Source: News